NeuBase Therapeutics, Inc. Quarterly Net Cash Provided by (Used in) Investing Activities in USD from Q4 2011 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
NeuBase Therapeutics, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q4 2011 to Q1 2023.
  • NeuBase Therapeutics, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending March 31, 2023 was -$4.95K, a 96.7% increase year-over-year.
  • NeuBase Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was -$472K, a 81.6% increase from 2021.
  • NeuBase Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was -$2.56M, a 258% decline from 2020.
  • NeuBase Therapeutics, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2020 was -$717K, a 4.61% decline from 2019.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$4.95K +$143K +96.7% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-11
Q4 2022 -$49.8K +$74.1K +59.8% Oct 1, 2022 Dec 31, 2022 10-QT 2023-06-05
Q1 2022 -$148K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$124K +$84.6K +40.6% Oct 1, 2021 Dec 31, 2021 10-QT 2023-06-05
Q4 2020 -$209K -$140K -205% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-11
Q4 2019 -$68.4K +$29.1K +29.8% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q4 2018 -$97.5K Oct 1, 2018 Dec 31, 2018 10-Q 2020-03-26
Q4 2016 -$4.83K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q4 2011 -$33.4K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.